Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein

Vaccine

Volumn 28, Issue 7, 2010, Pages 1766-1770

  Al Mariri, Ayman ^a  

^a DEPARTMENT OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Syrian Arab Republic)

Author keywords

Antigen; Cytokine; Immune response; Proliferation; Spleen

Indexed keywords

ESCHERICHIA COLI VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; PROTEIN P39;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BRUCELLOSIS; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; CELL PROLIFERATION; ESCHERICHIA COLI; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; PERIPLASMIC BINDING PROTEINS; SPLEEN; TH1 CELLS;

EID: 75249102114     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.012     Document Type: Article

References (40)

1. Al-Mariri A., Tibor A., Mertens P., DeBolle X., Michel P., Godefroid J., et al. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun 69 8 (2001) 4816-4822
2. Al-Mariri A., Tibor A., Mertens P., DeBolle X., Michel P., Godefroid J., et al. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect Immun 69 10 (2001) 6264-6270
3. Al-Mariri A., Tibor A., Lestrate P., Mertens P., DeBolle X., and Letesson J.-J. Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen. Infect Immun 70 4 (2002) 1915-1923
4. Alton G.G. Control of Brucella melitensis in sheep and goats-a review. Trop Anim Health Prod 19 2 (1987) 65-74
5. Andrews E., Salgado P., Folch H., and Oñate A. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide-dismutase. II. Induction of specific CD8+ cytotoxic lymphocytes and sensitized CD4+ IFN-gamma-producing cell. Microbiol Immunol 50 5 (2006) 389-393
6. Arenas G.N., Staskevich A.S., Aballay A., and Mayorga L.S. Intracellular trafficking of brucella abortus in J774 macrophages. Infect Immun 68 7 (2000) 4255-4263
7. Blasco J.M. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev Vet Med 31 3-4 (1997) 275-283
8. Boschiroli M.L., Foulongne V., and O'Callaghan D. Brucellosis: a worldwide zoonosis. Curr Opin Microbiol 4 1 (2001) 58-64
9. Corbel M.J. Brucellosis: an overview. Emerg Infect Dis 3 2 (1997) 213-321
10. Crespo L.F. Ovine and caprine brucellosis. Technical Reports Series (1994), OIE International des Epizooties, Paris pp. 12-35
11. Curtiss R., and Hassan J.O. Nonrecombinant and recombinant avirulent Salmonella vaccines for poultry. Vet Immunol Immunopathol 54 1-4 (1996) 365-372
12. de Bagüés Jimenez M.P., Dudal S., Dornand J., and Gross A. Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation. Clin Immunol 114 3 (2005) 227-238
13. DelVecchio V.G., Kapatral V., Redkar R.J., Patra G., Mujer C., Los T., et al. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc Natl Acad Sci USA 99 1 (2002) 443-448
14. Denoel P.A., Vo T.K., Weynants V.E., Tibor A., Gilson D., Zygmunt M.S., et al. Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB. J Med Microbiol 46 9 (1997) 801-806
15. Dornand J., Gross A., Lafont V., Liautard J., Oliaro J., and Liautard J.P. The innate immune response against Brucella in humans. Vet Microbiol 90 1-4 (2002) 383-394
16. FAO. A Perspective of Brucellosis surveillance in north Africa and the Middle East: Studies in Algeria - Iran - Kuwait - Morocco - Oman - Sudan and Syria. January 1998; GCP/REM/059/IFA. FAO Consultancy mission report.
17. Finke M., Duchene M., Eckhardt A., Domdey H., and von Specht B.U. Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli. Infect Immun 58 7 (1990) 2241-2244
18. Garin-Bastuji B., Blasco J.M., Grayon M., and Verger J.M. Brucella melitensis infection in sheep: present and future. Vet Res 29 3-4 (1998) 255-274
19. Golding B., Scott D.E., Scharf O., Huang L., Zaitseva M., Lapham C., et al. Immunity and protection against Brucella abortus. Microbes Infect 3 1 (2001) 43-48
20. Grilló M.J., Marín C.M., Barberán M., de Miguel M.J., Laroucau K., Jacques I., et al. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams. Vaccine 7 2 (2009) 187-191
21. Guilloteau L.A., Laroucau K., Vizcaino N., Jacques I., and Dubray G. Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB/c mice. Vaccine 17 4 (1999) 353-361
22. Higgins D., Marshall J.D., Traquina P., Van Nest G., and Livingston B.D. Immunostimulatory DNA as a vaccine adjuvant. Expert Rev Vaccines 6 5 (2007) 747-759
23. Ilvesaro J.M., Merrell M.A., Li L., Wakchoure S., Graves D., Brooks S., et al. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion. Mol Cancer Res 6 10 (2008) 1534-1543
24. Jacques I., Verger J.M., Laroucau K., Grayon M., Vizcaino N., Peix A., et al. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep. Vaccine 15 5 (2007) 794-805
25. Kohler S., Layssac M., Naroeni A., Gentschev I., Rittig M., and Liautard J.P. Secretion of listeriolysin by Brucella suis inhibits its intramacrophagic replication. Infect Immun 69 6 (2001) 2753-2756
26. Langermann S., Palaszynski S.R., Burlein J., Koenig E.S., Hanson M.S., Briles D.E., et al. Protective humoral response against pneumococcal infection in mice elicited by recombinant Bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A. J Exp Med 180 6 (1994) 2277-2286
27. Lara K., Rodrigo S., Zenaide M., Leonardo R., and Sílvio V. Brucella spp. isolation from dogs from commercial breeding kennels in São Paulo state, Brazil. Braz J Microbiol 35 1-2 (2004) 161-166
28. Marín C.M., Moreno E., Moriyón I., Díaz R., and Blasco J.M. Performance of competitive and indirect enzyme-linked immunosorbent assays, gel immunoprecipitation with native hapten polysaccharide, and standard serological tests in diagnosis of sheep brucellosis. Clin Diagn Lab Immunol 6 2 (1999) 269-272
29. Oñate A.A., Vemulapalli R., Andrews E., Schurig G.G., Boyle S., and Folch H. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect Immun 67 2 (1999) 986-988
30. Pappas G., Nikolaos A., Mile B., and Tsianos E. Brucellosis. N Engl J Med 352 22 (2005) 2325-2336
31. Pizarro-Cerda J., Moreno E., Sanguedolce V., Mege J.L., and Gorvel J.P. Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect Immun 66 5 (1998) 2387-2392
32. Refai M. Incidence and control of brucellosis in the near east region. Vet Mecrobiol 90 1-4 (2002) 81-110
33. Reichow Y.S., Ramamoorthy S., Ding X., Lathigra R., Craig J.C., Sobral B.W., et al. Brucella melitensis triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages. Infect Immun 74 9 (2006) 5035-5046
34. Scharp D.W., al Khalaf S.A., al Muhanna M.W., Cheema R.A., and Godana W. Use of mass vaccination with a reduced dose of Rev 1 vaccine for Brucella melitensis control in a population of small ruminants. Trop Anim Health Prod 31 3 (1999) 135-141
35. Singh M., and Srivastava I. Advances in vaccine adjuvants for infectious diseases. Curr HIV Res 10 10-11 (2003) 309-320
36. Singha H., Mallick A.I., Jana C., Isore D.P., Goswami T.K., Srivastava S.K., et al. Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus. Microbes Infect 10 3 (2008) 1089-1096
37. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76 9 (1979) 4350-4354
38. Vemulapalli R., He Y., Boyle S.M., Sriranganathan N., and Schurig G.G. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect Immun 68 6 (2000) 3290-3296
39. Zhan Y., and Cheers C. Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect Immun 61 11 (1993) 4899-4901
40. Zvizdic S., Cengic D., Bratic M., Mehanic S., Pinjo F., and Hamzic S. Brucella melitensis: review of the human infection case. Bosn J Basic Med Sci 6 1 (2006) 15-18